|
|
|
Insider
Information: |
Deese Willie A |
Relationship: |
Director |
City: |
Whitehouse Station |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
191,496 |
|
Indirect Shares
|
719 |
|
|
Direct
Value |
$19,208,873 |
|
|
Indirect Value
|
$94,333 |
|
|
Total
Shares |
192,215 |
|
|
Total
Value |
$19,303,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
16.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Merck & Co Inc |
MRK |
Exe V-P & Pres. MMD |
2016-02-22 |
133,759 |
2016-02-22 |
719 |
Premium* |
|
DENTSPLY International |
XRAY |
Director |
2024-04-12 |
35,099 |
2014-02-11 |
0 |
Premium* |
|
CDK Global Holdings Llc |
CDK |
Director |
2022-07-06 |
0 |
2014-11-14 |
0 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
|
2022-06-23 |
14,389 |
2021-06-17 |
0 |
Premium* |
|
Public Service Enterprise Group ... |
PEG |
Director |
2024-05-01 |
8,249 |
2022-05-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-01-27 |
4 |
OE |
$47.79 |
$1,433,700 |
D/D |
30,000 |
136,049 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-02-10 |
4 |
OE |
$48.24 |
$964,800 |
D/D |
20,000 |
156,049 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-02-10 |
4 |
S |
$54.68 |
$2,734,155 |
D/D |
(50,000) |
106,049 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-02-24 |
4 |
A |
$56.18 |
$569,440 |
D/D |
10,136 |
116,185 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-03-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
14,175 |
102,010 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-05-04 |
4 |
D |
$58.22 |
$200,801 |
D/D |
(3,449) |
106,222 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,659 |
109,671 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-06-27 |
4 |
AS |
$58.26 |
$4,211,254 |
D/D |
(72,290) |
106,222 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2014-06-27 |
4 |
OE |
$23.45 |
$2,013,164 |
D/D |
72,290 |
178,512 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2015-02-11 |
4 |
S |
$58.56 |
$7,956,372 |
D/D |
(135,864) |
106,230 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2015-02-11 |
4 |
OE |
$33.49 |
$5,494,524 |
D/D |
135,864 |
242,094 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2015-02-23 |
4 |
A |
$58.30 |
$510,825 |
D/D |
8,762 |
114,992 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2015-05-02 |
4 |
D |
$59.86 |
$205,799 |
D/D |
(3,438) |
119,193 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2015-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,636 |
122,631 |
0 |
- |
|
MRK |
Merck & Co Inc |
Exe V-P & Pres. MMD |
|
2016-02-22 |
4 |
A |
$50.77 |
$739,059 |
D/D |
14,557 |
133,759 |
0 |
- |
|
PEG |
Public Service Enterprise... |
Director |
|
2022-05-02 |
4 |
A |
$68.85 |
$180,043 |
D/D |
2,615 |
2,615 |
0 |
- |
|
PEG |
Public Service Enterprise... |
Director |
|
2023-05-01 |
4 |
A |
$63.14 |
$180,012 |
D/D |
2,851 |
5,562 |
0 |
- |
|
PEG |
Public Service Enterprise... |
Director |
|
2024-05-01 |
4 |
A |
$69.81 |
$180,040 |
D/D |
2,579 |
8,249 |
0 |
- |
|
93 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|